Drug name - Vyzulta

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8058467 BAUSCH AND LOMB Prostaglandin derivatives
Jan, 2025

(2 years from now)

US7910767 BAUSCH AND LOMB Prostaglandin derivatives
Jan, 2025

(2 years from now)

US7273946 BAUSCH AND LOMB Prostaglandin derivatives
Oct, 2025

(3 years from now)

CN100469765C BAUSCH AND LOMB Prostaglandin Nitroxide Derivative
Dec, 2024

(2 years from now)

CN1906159A BAUSCH AND LOMB The Prostaglandin Nitroxide Derivative
Dec, 2024

(2 years from now)

IN276779B BAUSCH AND LOMB Prostaglandin Nitrooxyderivatives
Dec, 2024

(2 years from now)

IN200603240P1 BAUSCH AND LOMB Prostaglandin Derivatives
Dec, 2024

(2 years from now)

EP1704141B1 BAUSCH AND LOMB Prostaglandin Nitrooxyderivatives
Dec, 2024

(2 years from now)

EP1704141A1 BAUSCH AND LOMB Prostaglandin Nitrooxyderivatives
Dec, 2024

(2 years from now)

EP3002277B1 BAUSCH AND LOMB Prostaglandin Derivatives
Dec, 2024

(2 years from now)

EP3002277A1 BAUSCH AND LOMB Prostaglandin Derivatives
Dec, 2024

(2 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7629345 BAUSCH AND LOMB Prostaglandin derivatives Jan, 2025

(2 years from now)

Drugs and Companies using LATANOPROSTENE BUNOD ingredient

Treatment: Reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.024% SOLUTION/DROPS;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.